Skip to content

OCRA Financial Stewardship

Financial Stewardship

Preserving The Public Trust

Transparency, Accountability, Stewardship

When you donate to OCRA, you can be sure your money is handled responsibly. By ensuring rigorous accountability, financial transparency, and meticulous stewardship of our donors’ funds, OCRA has earned the highest possible rating from Charity Navigator and a Platinum rating from Guidestar. We also meet the stringent Standards for Charity Accountability set forth by the Better Business Bureau’s Wise Giving Alliance.

 

Please explore this page to view our financial statements and policies.

Financial Information

Ovarian Cancer Research Alliance is a 501(c)(3) non profit organization. Our financial documents are public and available for viewing below.

Ovarian Cancer Research Alliance:

Organizations That Joined OCRA:

The following financial information is provided for historical reference for organizations that have merged with or become part of Ovarian Cancer Research Alliance. These documents reflect the most recent full year of financial reporting prior to each organization joining OCRA.

Rivkin Center for Ovarian Cancer

The Clearity Foundation

Ovarian Cancer National Alliance

Policies

A 501(c)(3) organization, Ovarian Cancer Research Alliance receives funding from individual donors, foundations, corporations, and cause-marketing initiatives. Individual solicitations, direct mail, fundraising events, grant proposals, sponsorships, product sales, and special projects secure these funds.

Our mission is to remain objective in providing information to the ovarian cancer community; we do not endorse any particular treatment, therapy, clinical trial or product.

Ovarian Cancer Research Alliance is committed to:

  • Ensuring that fundraising complies with all applicable federal and state regulations, including appropriate registrations, annual filings, and audits to comply with the Internal Revenue Code;
  • Providing the public with access to its most recent financial reports and filings;
  • Maintaining the confidentiality of donors’ information and ensuring any disclosures comply with all applicable laws;
  • Accepting contributions from sources such as individuals, foundations, and for-profit institutions while ensuring that the positions of Ovarian Cancer Research Alliance on policy issues are never unduly or improperly influenced by contributors.

Conflict of Interest Statement — Industry Partners

  • Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
  • In 2023, industry partners represented 8% of OCRA’s overall revenue.
  • If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
  • Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.

Related Topics

AWS Highlights OCRA’s Research Exchange in $100 Million Health Impact Initiative

AWS Highlights OCRA’s Research Exchange in $100 Million Health Impact Initiative

Recognition underscores the potential of OCRA’s innovative approach to accelerating gynecologic cancer research through AI, data sharing, and collaboration. Amazon Web Services (AWS) has launched its Health Impact Initiative, a $100 million, five-year commitment to putting AI, advanced computing, and cloud infrastructure in the hands of organizations working to address some of the world’s most … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.